Rising Pharma Holding recalls

Rising Pharma Holding has 13 recalls on record with the FDA and USDA, the earliest in 2024 and the latest reported on 29 Jul 2026. 13 are still ongoing. 3 were reported in the last 12 months. The most frequent reason is nitrosamine impurity.

Total recalls13since 2024

Last 12 months3reported

Class I00% of total

Ongoing13latest 29 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 3 3 0Feb 1 0 0May 0 0 0Aug 0 1 0Nov 0 0 0Feb 1 0 0May 0 1 0Aug 0 0

Severity split

Class I 0 0%Class II 11 85%Class III 2 15%

Why rising pharma holding is recalled

Product types

Brands

By year

2026215%
2025538%
2024646%

Ongoing rising pharma holding recalls

13 active

Reported	Class	Recall	Company	Reason	Where
29 Jul 2026Drug	CLASS II	Rising, Cyproheptadine Hydrochloride Syrup, 2mg recalledCyproheptadine Hydrochloride	Rising Pharma Holding	Particulate Matter	Nationwide
11 Mar 2026Drug	CLASS II	Product label: Temozolomide Capsules, 5mg recalledTemozolomide	Rising Pharma Holding	Potency & Assay	Nationwide
22 Oct 2025Drug	CLASS II	Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg recalledCarbidopa, Levodopa And Entacapone	Rising Pharma Holding	Packaging Defects	Nationwide
26 Mar 2025Drug	CLASS II	Duloxetine Delayed-Release Capsules, USP, 30 mg recalled	Rising Pharma Holding	Nitrosamine Impurity	Nationwide
15 Jan 2025Drug	CLASS II	Duloxetine Delayed-Release Capsules USP 20 mg recalled	Rising Pharma Holding	Nitrosamine Impurity	Nationwide
15 Jan 2025Drug	CLASS II	Duloxetine DR Capsules USP 60 mg, a) recalled by Rising Pharma Holding	Rising Pharma Holding	Nitrosamine Impurity	Nationwide

All rising pharma holding recalls, newest first

13 total

Reported	Class	Recall	Company	Reason	Where
29 Jul 2026Drug	CLASS II	Rising, Cyproheptadine Hydrochloride Syrup, 2mg recalledCyproheptadine Hydrochloride	Rising Pharma Holding	Particulate Matter	Nationwide
11 Mar 2026Drug	CLASS II	Product label: Temozolomide Capsules, 5mg recalledTemozolomide	Rising Pharma Holding	Potency & Assay	Nationwide
22 Oct 2025Drug	CLASS II	Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg recalledCarbidopa, Levodopa And Entacapone	Rising Pharma Holding	Packaging Defects	Nationwide
26 Mar 2025Drug	CLASS II	Duloxetine Delayed-Release Capsules, USP, 30 mg recalled	Rising Pharma Holding	Nitrosamine Impurity	Nationwide
15 Jan 2025Drug	CLASS II	Duloxetine Delayed-Release Capsules USP 20 mg recalled	Rising Pharma Holding	Nitrosamine Impurity	Nationwide
15 Jan 2025Drug	CLASS II	Duloxetine DR Capsules USP 60 mg, a) recalled by Rising Pharma Holding	Rising Pharma Holding	Nitrosamine Impurity	Nationwide
15 Jan 2025Drug	CLASS II	Duloxetine Delayed-Release Capsules USP 30 mg, a) recalled	Rising Pharma Holding	Nitrosamine Impurity	Nationwide
11 Dec 2024Drug	CLASS II	Duloxetine Delayed-Release Capsules USP, 20 mg recalled	Rising Pharma Holding	Nitrosamine Impurity	Nationwide
11 Dec 2024Drug	CLASS II	Duloxetine Delayed-Release Capsules USP, 30 mg, a) recalled	Rising Pharma Holding	Nitrosamine Impurity	Nationwide
11 Dec 2024Drug	CLASS II	Duloxetine DR Capsules USP 60 mg, a) recalled by Rising Pharma Holding	Rising Pharma Holding	Nitrosamine Impurity	Nationwide
17 Jul 2024Drug	CLASS III	Diflorasone Diacetate Ointment, USP, 0.05% tube recalledDiflorasone Diacetate	Rising Pharma Holding	Potency & Assay	Nationwide
12 Jun 2024Drug	CLASS III	Pregabalin Capsules 50mg recalled by Rising Pharma HoldingPregabalin	Rising Pharma Holding	Packaging Defects	Nationwide
17 Jan 2024Drug	CLASS II	buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg recalled	Rising Pharma Holding	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.